Journal of Neuroimmunology

Article	Citations
SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation	91
A systematic review of cases of CNS demyelination following COVID-19 vaccination	86
A case of longitudinally extensive transverse myelitis following vaccination against Covid-19	75
The emerging role of the BDNF-TrkB signaling pathway in the modulation of pain perception	70
The pathogenic, therapeutic and diagnostic role of exosomal microRNA in the autoimmune diseases	69
Safety and efficacy of COVID-19 vaccines in multiple sclerosis patients	66
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study	65
Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms	57
Inflammation in Huntington's disease: A few new twists on an old tale	54
The neutrophil-to-lymphocyte ratio in Alzheimer's disease: Current understanding and potential applications	52
Stellate ganglion block reduces symptoms of Long COVID: A case series	47
Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature	43
The role of damage associated molecular pattern molecules (DAMPs) and permeability of the blood-brain barrier in depression and neuroinflammation	40
AstraZeneca COVID-19 vaccine and Guillain- Barré Syndrome in Tasmania: A causal link?	39
The involvement of JAK/STAT signaling pathway in the treatment of Parkinson's disease	39
New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure	39
Update on the management of multiple sclerosis during the COVID-19 pandemic and post pandemic: An international consensus statement	37
Toll-like receptors in Alzheimer's disease	37
Stiff person syndrome spectrum disorders; more than meets the eye	35
Multipotential and systemic effects of traumatic brain injury	34
Acute transverse myelitis with Dysautonomia following SARS-CoV-2 infection: A case report and review of literature	33
COVID-19-related encephalopathy presenting with aphasia resolving following tocilizumab treatment	33
Modulation of the HMGB1/TLR4/NF-κB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis	33
Hyperacute reversible encephalopathy related to cytokine storm following COVID-19 vaccine	32
A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease	32

LncRNA NEAT1/miR-128-3p/AQP4 axis regulating spinal cord injury-induced neuropathic pain progression	31
A case of area postrema variant of neuromyelitis optica spectrum disorder following SARS-CoV-2 infection	30
The microglial NLRP3 inflammasome is involved in human SARS-CoV-2 cerebral pathogenicity: A report of three post-mortem cases	29
Probiotics protect against gut dysbiosis associated decline in learning and memory	29
Anti-MAG neuropathy: From biology to clinical management	29
Cerebrospinal fluid immune markers and HIV-associated neurocognitive impairments: A systematic review	29
Clinical, neuroradiological, diagnostic and prognostic profile of autoimmune glial fibrillary acidic protein astrocytopathy: A pooled analysis of 324 cases from published data and a single-center retr	29
Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?	29
Association of Guillain-Barre syndrome with COVID-19 infection: An updated systematic review	27
Knockdown of miR-130a-3p alleviates spinal cord injury induced neuropathic pain by activating IGF-1/IGF-1R pathway	27
NMOSD acute attack: Understanding, treatment and innovative treatment prospect	27
Disease-modifying therapies and progressive multifocal leukoencephalopathy in multiple sclerosis: A systematic review and meta-analysis	26
New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine	24
Herpesviruses and the hidden links to Multiple Sclerosis neuropathology	24
COVID-19, HHV6 and MOG antibody: A perfect storm	22
Ferroptosis as a mechanism of oligodendrocyte loss and demyelination in experimental autoimmune encephalomyelitis	22
Acute disseminated encephalomyelitis and COVID-19: A systematic synthesis of worldwide cases	22
Gut microbial metabolite TMAO portends prognosis in acute ischemic stroke	22
Aseptic meningitis and leptomeningeal enhancement associated with anti-MOG antibodies: A review	22
Safety and efficacy of rituximab for relapse prevention in myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG)-associated disorders (MOGAD): A systematic review and meta-analysis	21
The second brain: The connection between gut microbiota composition and multiple sclerosis	21
Salivary GFAP as a potential biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease and its correlation with neuroinflammation and apoptosis	21
Initial clinical manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine	20
Longitudinally extensive transverse myelitis with anti-myelin oligodendrocyte glycoprotein antibodies following SARS-CoV-2 infection	20
Thyroid hormone and thyromimetics inhibit myelin and axonal degeneration and oligodendrocyte loss in EAE	20
Clinical features and diagnosis of neurosarcoidosis – review article	19
Protective effect of scorpion venom heat-resistant synthetic peptide against PM2.5-induced microglial polarization via TLR4-mediated autophagy activating PI3K/AKT/NF-κB signaling pathway	19
Bortezomib in anti-N-Methyl-d-Aspartate-Receptor (NMDA-R) encephalitis: A systematic review	18
Evidence for and against subclinical disease activity and progressive disease in MOG antibody disease and neuromyelitis optica spectrum disorder	18
Efficacy and safety of bortezomib in rituximab-resistant anti-N-methyl-d-aspartate receptor (anti-NMDAR) encephalitis as well as the clinical characteristics: An observational study	18
The multifactorial roles of microglia and macrophages in the maintenance and progression of glioblastoma	18
C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD	17
Serum level of IL-1β in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD)	17
Epidemiology of neuronal surface antibody-mediated autoimmune encephalitis and antibody-based diagnostics	17
Extracellular cardiolipin modulates microglial phagocytosis and cytokine secretion in a toll-like receptor (TLR) 4-dependent manner	17
Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: A case series	16
12-months prospective Pentraxin-3 and metabolomic evaluation in multiple sclerosis patients treated with glatiramer acetate	16
Low-dose rituximab lowers serum Exosomal miR-150-5p in AChR-positive refractory myasthenia gravis patients	16
Association between plasma neurofilament light chain levels and cognitive function in patients with Parkinson's disease	16
The changing spectrum of antibody-mediated encephalitis in China	16
HMGB1 plays an important role in pyroptosis induced blood brain barrier breakdown in diabetes-associated cognitive decline	16
Crosstalk between gut microbiome and immunology in the management of ischemic brain injury	16
Central nervous system (CNS) inflammatory demyelinating diseases (IDDs) associated with COVID-19: A case series and review	16
Potential autoimmune encephalitis following yellow fever vaccination: A report of three cases	16
Post-infectious rhombencephalitis after coronavirus-19 infection: A case report and literature review	15
Interleukin-1β in peripheral monocytes is associated with seizure frequency in pediatric drug-resistant epilepsy	15
Hippocampal microglia CD40 mediates NPSLE cognitive dysfunction in mice	15
High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis	15
Genetic basis of Guillain-Barre syndrome	15
The neuroprotective effects and transdifferentiation of astrocytes into dopaminergic neurons of Ginkgolide K on Parkinson’ disease mice	15

Progression pattern of neurological disability with respect to clinical attacks in anti-MOG antibody-associated disorders	14
Selective modulation of trans-endothelial migration of lymphocyte subsets in multiple sclerosis patients under fingolimod treatment	14
TREM2, microglial and ischemic stroke	14
Predictors of hypogammaglobulinemia and serious infections among patients receiving ocrelizumab or rituximab for treatment of MS and NMOSD	14
Low-dose rituximab treatment for new-onset generalized myasthenia gravis	14
Neuropathological spectrum in systemic lupus erythematosus: A single institute autopsy experience	14
Aging and the immune response in diabetic peripheral neuropathy	14
Innate immunity, inflammation activation and heat-shock protein in COVID-19 pathogenesis	13
Are sensory neurons exquisitely sensitive to interleukin 1β?	13
Assessing the role of a tissue-based assay in the diagnostic algorithm of autoimmune encephalitis	13
Humoral immune response in convalescent COVID-19 people with multiple sclerosis treated with high-efficacy disease-modifying therapies: A multicenter, case-control study	13
Microglia mediated neuroinflammation in neurodegenerative diseases: A review on the cell signaling pathways involved in microglial activation	13
Plasma levels of nerve growth factor in Egyptian autistic children: Relation to hyperserotonemia and autoimmunity	13
Lymphocyte-based ratios for predicting respiratory failure in Guillain-Barré syndrome	13
A bibliometric evaluation of the top 100 cited natalizumab articles	13
Elevated levels of IL-32 in cerebrospinal fluid of neuro-Behcet disease: Correlation with NLRP3 inflammasome	13
Analysis of plasma protein biomarkers in childhood onset multiple sclerosis	13
Altered distributions and functions of natural killer T cells and γδ T cells in neonates with neonatal encephalopathy, in school-age children at follow-up, and in children with cerebral palsy	13
Long-term cognitive and neuropsychiatric outcomes of anti-GABABR encephalitis patients: A prospective study	13
Programmed death protein 1 is essential for maintaining the anti-inflammatory function of infiltrating regulatory T cells in a murine spinal cord injury model	12
COVID-19 mRNA vaccine-associated encephalopathy, myocarditis, and thrombocytopenia with excellent response to methylprednisolone: A case report	12
Prognostic value of acute cerebrospinal fluid abnormalities in antibody-positive autoimmune encephalitis	12
Pretreatment neutrophil-to-lymphocyte/monocyte-to-lymphocyte ratio as prognostic biomarkers in glioma patients	12
Efficacy of plasma exchange in acute attacks of neuromyelitis optica spectrum disorders: A systematic review and meta-analysis	12
Seasonal variation of onset in patients with anti-aquaporin-4 antibodies and anti-myelin oligodendrocyte glycoprotein antibody	12
Intestinal permeability correlates with behavioural severity in very young children with ASD: A preliminary study	12
Seasonal variation in autoimmune encephalitis: A multi-center retrospective study	12
The role of 5-HT2B-receptors in fluoxetine-mediated modulation of Th17- and Th1-cells in multiple sclerosis	12
Elevated inflammatory proteins in cerebrospinal fluid from patients with painful knee osteoarthritis are associated with reduced symptom severity	12
Covid-19 systemic infection exacerbates pre-existing acute disseminated encephalomyelitis (ADEM)	12
Peripheral neuropathy in sarcoidosis	11
Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and	11
Microglial depletion exacerbates motor impairment and dopaminergic neuron loss in a 6-OHDA model of Parkinson's disease	11
Humoral and cellular immunity in convalescent COVID-19 people with multiple sclerosis treated with ofatumumab	11
Sequential expression of neutrophil chemoattractants in cerebrospinal fluid after subarachnoid hemorrhage	11
Relationship of selective complement markers with schizophrenia	11
CNS demyelination with TNFα inhibitor exposure: A retrospective cohort study	11
Antibodies to the α3 subunit of the ganglionic-type nicotinic acetylcholine receptors in patients with autoimmune encephalitis	11
B cell depletion changes the immune cell profile in multiple sclerosis patients: One-year report	10
Ponesimod modulates the Th1/Th17/Treg cell balance and ameliorates disease in experimental autoimmune encephalomyelitis	10
The protective effects of neural stem cells and neural stem cells-conditioned medium against inflammation-induced prenatal brain injury	10
Acute haemorrhagic leukoencephalitis (AHLE) – our experience and a short review	10
L-methionine enhances neuroinflammation and impairs neurogenesis: Implication for Alzheimer's disease	10
The combination of C C chemokine receptor type 5(CCR5) and Treg cells predicts prognosis in patients with ischemic stroke	10
PARKIN modifies peripheral immune response and increases neuroinflammation in active experimental autoimmune encephalomyelitis (EAE)	10
Enterovirus A71 causing meningoencephalitis and acute flaccid myelitis in a patient receiving rituximab	10
Cladribine treatment for highly active multiple sclerosis: Real-world clinical outcomes for years 3 and 4	10
The clinical need for clustered AChR cell-based assay testing of seronegative MG	10
Atypical myelin oligodendrocyte glycoprotein antibody–associated optic neuritis and acute demyelinating polyneuropathy after SARS-CoV-2 infection: Case report and literature review	10
Involvement and relationship of bacterial lipopolysaccharides and cyclooxygenases levels in Alzheimer's Disease and Mild Cognitive Impairment patients	10
Autoimmune encephalitis misdiagnosis and mimics	10
The TLR4 mediated inflammatory signal pathway might be involved in drug resistance in drug-resistant epileptic rats	10
Microglial proliferation attenuates sickness responses in adult mice during endotoxin-induced inflammation	10
Comparison of clinical characteristics and prognoses in patients with different AQP4-Ab and MOG-Ab serostatus with neuromyelitis optica spectrum disorders	10
Insomnia and depressive behavior of MyD88-deficient mice: Relationships with altered microglial functions	10
IL-6 as a marker for NMOSD disease activity	10
Estriol in regulation of cell-mediated immune reactions in multiple sclerosis	10
Brain astrocytes and microglia express functional MR1 molecules that present microbial antigens to mucosal-associated invariant T (MAIT) cells	10
Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer	10
Complete Freund's adjuvant-free experimental autoimmune encephalomyelitis in Dark Agouti rats is a valuable tool for multiple sclerosis studies	9
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma	9
A potent and selective CXCR2 antagonist improves neuroimmune dysregulation through the inhibition of NF-κB and notch inflammatory signaling in the BTBR mouse model of autism	9
Inflammatory profiles in plasma and cerebrospinal fluid of patients with neurosarcoidosis	9
A mucosal immune response induced by oral administration of heat-killed Mycobacterium avium subsp. paratuberculosis exacerbates EAE	9
A paraneoplastic syndrome misdiagnosed as ALS: What are the red flags? A case report and review of the literature	9
The CSF in neurosarcoidosis contains consistent clonal expansion of CD8 T cells, but not CD4 T cells	9
Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis	9
Doxycycline alleviates acute traumatic brain injury by suppressing neuroinflammation and apoptosis in a mouse model	9
Upregulation of interleukin (IL)-31, a cytokine producing CXCR1 peripheral immune cells, contributes to the immune abnormalities of autism spectrum disorder	9
LRP4-IgG service line testing in seronegative myasthenia gravis and controls	9
Protection induced by estradiol benzoate in the MPP+ rat model of Parkinson's disease is associated with the regulation of the inflammatory cytokine profile in the nigro striatum	9
Guillain-Barré syndrome associated with SARS-CoV-2 infection: A case report with long term follow up	9
Autoimmune glial fibrillary acidic protein astrocytopathy resembling isolated central nervous system lymphomatoid granulomatosis	9
Sub-basal increases of GABA enhance the synthesis of TNF-α, TGF-β, and IL-1β in the immune system organs of the Nile tilapia	8
Enrichment of serum IgG4 in MuSK myasthenia gravis patients	8
T cells show preferential adhesion to enteric neural cells in culture and are close to neural cells in the myenteric ganglia of Crohn's patients	8
Treg and IL-1 receptor type 2-expressing CD4+ T cell-deleted CD4+ T cell fraction prevents the progression of age-related hearing loss in a mouse model	8
Repeated administration of LPS exaggerates amphetamine-induced locomotor response and causes learning deficits in mice	8
Expression analysis of NF-κB-associated long noncoding RNAs in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients	8
Pediatric anti-N-methyl-d-aspartate receptor encephalitis in southern China: Analysis of 111 cases	8

Ovariectomy increases paclitaxel-induced mechanical hypersensitivity and reduces anti-inflammatory CD4+ T cells in the dorsal root ganglion of female mice	8
The role of multiple sclerosis therapies on the dynamic of human gut microbiota	8
Tissue-resident memory T cells in the multiple sclerosis brain and their relationship to Epstein-Barr virus infected B cells	8
Modelling multiple sclerosis using induced pluripotent stem cells	8
Characterization of cerebral small vessel disease by neutrophil and platelet activation markers using artificial intelligence	8
Characterization, isolation, and in vitro culture of leptomeningeal fibroblasts	8
Prevalence of iatrogenic CNS inflammation at a tertiary neuroimmunology clinic	8
Papaverine provides neuroprotection by suppressing neuroinflammation and apoptosis in the traumatic brain injury via RAGE- NF-<kappa>B pathway	8
Opsoclonus-myoclonus syndrome associated with anti Kelch-like protein-11 antibodies in a young female patient without cancer	8
Evaluation of effect of empirical attack-preventive immunotherapies in neuromyelitis optica spectrum disorders: An update systematic review and meta -analysis	7
AChR-and MuSK-positive myasthenia gravis: Double trouble	7
Eculizumab treatment for myasthenia gravis subgroups: 2021 update	7
Converging purinergic and immune signaling pathways drive IL-6 secretion by Fragile X cortical astrocytes via STAT3	7
Overcoming the challenges in diagnosis of AQP4-IgG positive neuromyelitis optica spectrum disorders in resource poor settings using an indigenized and cost effective cell based assay	7
Serum cytokine and chemokine profiles in patients with immune-mediated necrotizing myopathy	7
Profiling serum neurofilament light chain and glial fibrillary acidic protein in primary progressive multiple sclerosis	7
Longitudinally extensive transverse myelitis as a sign of multisystem inflammatory syndrome following COVID-19 infection: A pediatric case report	7
Structural and biochemical imaging reveals systemic LPS-induced changes in the rat brain	7
Prolonged STAT1 activation in neurons drives a pathological transcriptional response	7
Anti-GM1 IgM antibody positive axonal variant of Guillain-Barre-syndrome in a pediatric patient with dengue fever	7
Rescue immunoadsorption treatment for neuromyelitis optica spectrum disorder attacks unresponsive to intravenous methylprednisolone	7
Adenylate kinase 5 (AK5) autoimmune encephalitis: Clinical presentations and outcomes in three new patients	7
Corticosteroids lead to short-term improvement in cerebral amyloid angiopathy-related inflammation	7
Ski regulates proliferation and migration of reactive astrocytes induced by lipopolysaccharide (LPS) through PI3K/Akt pathway	7
Tocilizumab as an alternative for corticosteroid-refractory orbital myositis	7
Endocannabinoid system: Role in blood cell development, neuroimmune interactions and associated disorders	7
Immunological effects of dimethyl fumarate treatment in blood and CSF of patients with primary progressive MS	7
Prostaglandin E2 increases the expression of cyclooxygenase-2 in cultured rat microglia.	7
IgG intrathecal synthesis in HIV-associated neurocognitive disorder (HAND) according to the HIV-1 subtypes and pattern of HIV RNA in CNS and plasma compartments	7
Modeling compartmentalized chronic immune-mediated demyelinating CNS disease in the Biozzi ABH mouse	7
Myelin oligodendrocyte glycoprotein (MOG) antibodies in a patient with glioblastoma: Red flags for false positivity	7
Emerging role of extracellular vesicles in multiple sclerosis: From cellular surrogates to pathogenic mediators and beyond	7
Alterations in peripheral blood monocyte and dendritic cell subset homeostasis in relapsing-remitting multiple sclerosis patients	7
Oral D-mannose treatment suppresses experimental autoimmune encephalomyelitis via induction of regulatory T cells	7
INFβ treatment affects global DNA methylation in monocytes of patients with multiple sclerosis	7
Matrine mediated neuroprotective potential in experimental multiple sclerosis: Evidence from CSF, blood markers, brain samples and in-silico investigations	7
Age- and sex-dependent alterations in the peripheral immune system in the 3xTg-AD mouse model of Alzheimer's disease: Increased proportion of CD3+CD4-CD8- double-negative T cells in the blood	6
Primary angiitis of the central nervous system – A challenging diagnosis	6
AMPAR autoimmunity: Neurological and oncological accompaniments and co-existing neural autoantibodies	6
Anti-FGFR3 antibody epitopes are functional sites and correlate with the neuropathy pattern	6
Myelin oligodendrocyte glycoprotein-associated disease is associated with BANK1, RNASET2 and TNIP1 polymorphisms	6
The identification, development and therapeutic potential of IL-10-producing regulatory B cells in multiple sclerosis	6
Comparison of the clinical syndromes of anti-GABAa versus anti-GABAb associated autoimmune encephalitis: A systematic review	6
Altered immunoemotional regulatory system in COVID-19: From the origins to opportunities	6
The microglial endocannabinoid system is similarly regulated by lipopolysaccharide and interferon gamma	6
Disrupting RhoA activity by blocking Arhgef3 expression mitigates microglia-induced neuroinflammation post spinal cord contusion	6
Brain stem encephalitis is a rare complication of COVID-19	6
The case report of AQP4 and MOG IgG double positive NMOSD treated with subcutaneous Ofatumumab	6
Do peripheral immune and neurotrophic markers correlate with motor severity of Parkinson's disease?	6
Regulatory T cells in children with attention deficit hyperactivity disorder: A case-control study	6
MINI-review of Epstein-Barr virus involvement in multiple sclerosis etiology and pathogenesis	6
Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder	6
The neuroprotective function of 2-carba-cyclic phosphatidic acid: Implications for tenascin-C via astrocytes in traumatic brain injury	6
Prophylactic exposure to oral riluzole reduces the clinical severity and immune-related biomarkers of experimental autoimmune encephalomyelitis	6
Infiltration of peripheral immune cells into the olfactory bulb in a mouse model of acute nasal inflammation	6
Calcitriol modulate post-ischemic TLR signaling pathway in ischemic stroke patients	6
Serum amyloid A level correlates with T2 lesion volume and cortical volume in patients with multiple sclerosis	6
MOG autoimmunity mimicking CLIPPERS syndrome: Case report and literature review	6
The effect of early life immune challenge on adult forced swim test performance and hippocampal neurogenesis	6
Atypical clinical and novel radiological findings in Susac syndrome: Experience from a large monocentric cohort	6
Neuro-ophthalmological manifestations of sarcoidosis	6
Autoimmune GFAP astrocytopathy presenting with remarkable CNS hyperexcitability and oculogyric crises	6
Interleukin-17 is involved in neuropathic pain and spinal synapse plasticity on mice	6
Cerebrospinal fluid soluble CD27 is associated with CD8+ T cells, B cells and biomarkers of B cell activity in relapsing-remitting multiple sclerosis	6
The therapeutic effect of ofatumumab in autoimmune encephalitis: A case series	6
Priming of microglia by type II interferon is lasting and resistant to modulation by interleukin-10 in situ	6
Hydroxychloroquine alleviates the neurotoxicity induced by anti-ribosomal P antibodies	6
Quantitative analysis of spinal cord neuropathology in experimental autoimmune encephalomyelitis	6
Alterations in brainstem respiratory centers following peripheral inflammation: A systematic review	6
Three cases of rheumatoid meningitis with elevated CSF neopterin levels	6
Cryptogenic new-onset refractory status epilepticus responded to anti-interleukin-6 treatment	6
Distinguishing CNS neurosarcoidosis from multiple sclerosis and an approach to “overlap” cases	6